Monthly Archives: February 2017

National Workshop on GCP, Bioethics and Conference on Strategies in conducting clinical trials | March 24 & 25, 2017 | DSMCH,Perambalur

I am Dr. Natesh Prabhu | Co-Organising secretary for this event and the President of Indian Medical Pharmacologists Association. I want you all to know what makes this event a special one and a must to attend. Kindly read this and share it with your peers!
This is one of my “dream come true moment”, having an exclusive National workshop cum conference organized right from the IMPA headquarters. It has been just more than two years now and we, at IMPA, are able to come forward with such a big event. First of all I would like to thank my team and management, Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur, who are supporting us by all possible means.
*What’s special about this event?*
You may think this is one other workshop/conference where there will be lectures with parallel poster presentations. You are right. But what makes this special are the speakers. Many of the speakers are part of IMPA team right from beginning. They have seen us progressing through tough times. And this gives me immense sense of satisfaction and pleasure to have them on the dais delivering the lectures. As you can see from our program schedule that first day is the Workshop on Good Clinical Practices & Bioethics. Currently, the significance of GCP & Bioethics training/certification is growing up as the rules & regulations stating the requirements of GCP/Bioethics certified staffs in the panel of ethics committee, journal editors/reviewers, CRO employees and any researchers working on clinical trials. With the investigator-initiated clinical trials picking up pace in the tier two and three cities, the need for GCP certification is coming up at the cost of few thousands and mostly all are online courses with substandard trainers. To overcome these shortcomings, we have invited faculties from premier research centers, academia and industries to train the participants. One full day of brain-storming training on GCP & Bioethics will give the participants confidence towards ethical and standardized conductance of research.
The second day will be the conference on Strategies in Conducting Clinical Trial. Starting from First–in Human studies to Post marketing studies, we have invited speakers who are currently working in or have actually worked on that particular field of their talk. This makes the talk very sensible as they speak their heart out based on their actual experience. We have certainly avoided calling in irrelevant speakers just for the sake of courtesy, which again make this event special. To end the event, we have two interesting sessions on “Concepts in Conducting Trials with Medical Devices” and “Role of Clinical Pharmacologists in Research”. Medical devices trial laws and regulations are evolving fast in India, with MoHFW releasing the Medical Devices Rules, 2017. This rule, unless specified otherwise, shall come into force with effect from 1st day of January, 2018. Therefore this dedicated session on medical devices trials will benefit the clinicians who, in future can be a principal investigator at their organization. Finally my mentor, Dr.Ram Mohan will be delivering a consolidated talk about the various roles of clinical pharmacologists, right from being a teacher to senior advisor/vice president in a pharmaceutical company.
Second day will also have parallel sessions for oral and poster presentations exclusively on Clinical Trials: Either as an original research or clinical trial reviews/Emerging trends in clinical trials. The winners will be awarded with certificates and prizes.
Lastly, as team IMPA envisaged, there is going to be an event, which is exclusively framed for MD/DM pharmacologists with the target audience being us, the Indian Medical Pharmacologists. Hereby, we shall UNITE, EXPLORE & INNOVATE!


Early Bird Registration (Before 7th March):
For faculty: 1500 INR
For post-graduate: 1000 INR

Late Registration (After 7th March):
For faculty: 1700 INR
For post-graduate: 1200 INR

Spot Registration (No Guarantee for Kit):
For faculty: 2000 INR
For post-graduate: 1500 INR

(PG students should attach their BONA FIDE CERTIFICATE from their HOD/institution)

Account Details (For Online Transfer / NEFT):

Bank Name: Indian Overseas Bank, Siruvachur
Account No.: 227301000006469
IFSC Code: IOBA0002273

Registration with Demand Draft:
Enclose a Demand Draft in favour of “NATIONAL WORKSHOP ON GCP BIOETHICS”, payable at Siruvachur, Perambalur

Delegates are expected to arrange for their own accommodation. Hostel accomodations are availble on a sharing basis. Rs: 300 per person / day.
For list of hotels in and around perambalur, click here

Dhanalakshmi Srinivasan Medical College & Hospital (DSMCH) is situated in Siruvachur, NH-45 highway: 253Km from Chennai Airport towards Trichy, 285 Km from Chennai Central Railway Junction towards Trichy, 56 Km from Trichy Railway Junction towards Chennai. The college is well-connected by bus facilities from the Chennai Mofussil Bus Terminus (CMBT), Koyambedu, towards Trichy.

Dr. Surendra Kumar Bouddh
Chief Organizing Secretary, Professor,
Department of Pharmacology,
Dhanalakshmi Srinivasan Medical College & Hospital, Siruvachur-621113, Perambalur, Tamilnadu, Mobile: +919442533490
Dr. Natesh Prabhu (+919585890660)
Co – Organising Secretary, Assistant Professor, Dept. Of Pharmacology

Paper Presentation theme: Clinical trials
Best 10 abstracts will be selected for Poster Presentation
Best 20 abstracts will be selected for Oral presentation
* 10 abstracts on “Original Research” Catergory
* 10 abstracts on “Clinical Trial Reviews” and “Emerging Trends in Clinical Trials” category
Send your abstracts to on or before March 12, 2017 | Confirmation of acceptance / Rejection to be sent before March 19, 2017
For further details contact Dr. Sandeep Kumar Gupta: +91-8940016928
For guidelines, click here


A curious case of “Medzol clone”

Originally trademarked by Themis (Mumbai Based Company) for Midazolam since 2012. Recently a pune based company named Medtab Pharma, released its product pantoprazole in the same name: Medzol (Med – MEDtab pharma | Zol – PantopraZOLe). This created a big ruffle on the social media. And based on our group discuss we concluded this to be photoshopped which was proven wrong by an order released from Directorate of FDA, Goa saying that both the medications are different and people in health care sectors should be careful about this. (…/0BwEuX8U-TTgCRUhELVNETWdHRDA/view)

Recently, based on mail exchanges (Screen Shots attached below) we came to know the actual truth. Themis had asked Medtab pharma to withdraw the product from public use for which Medtab pharma agreed.

This once again reveals how lethargic and not-focused our Indian drug regulators are.

Share this and spread the message!